Mixed gas microbubble compositions

• US 6,953,569 B2
• Filed: 12/19/2001
• Issued: 10/11/2005
• Est. Priority Date: 07/30/1993
• Status: Expired due to Fees

• Current Assignee: Targeson, Inc.
• Original Assignee: IMCOR Pharmaceutical Company
• Inventors: Schutt, Ernest G., Weers, Jeffry G., Anderson, Charles David, Kinner, Rene Alta, Evitts, David P.
• Primary Examiner(s): HARTLEY, MICHAEL G
• Application Number:
  US10/029,712
• Publication Number:
  US 20020098151A1
• Time in Patent Office: 1,392 Days
• Field of Search: 424/9.52, 424/9.51, 424/9.5
• US Class Current: 424/9.52
• CPC Class Codes: A61K 49/223 Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
• CPC Class Codes: A61K 49/227 Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
• CPC Class Codes: G02B 6/0006 Coupling light into the fibre in general G02B6/4298

Abstract

A microbubble preparation formed of a plurality of microbubbles comprising a first gas and a second gas surrounded by a membrane such as a surfactant, wherein the first gas and the second gas are present in a molar ratio of from about 1:100 to about 1000:1, and wherein the first gas has a vapor pressure of at least about (760−x) mm Hg at 37 C., where x is the vapor pressure of the second gas at 37 C., and wherein the vapor pressure of each of the first and second gases is greater than about 75 mm Hg at 37 C.; also disclosed are methods for preparing microbubble compositions, including compositions that rapidly shrink from a first average diameter to a second average diameter less than about 75% of the first average diameter and are stabilized at the second average diameter; kits for preparing microbubbles; and methods for using such microbubbles as ultrasound contrast agents.

Claims

1. An injectable ultrasound contrast agent comprising:

(a) a suspension of gas filled microbubbles or microballoons in a physiologically acceptable aqueous carrier comprising surfactants, and additives wherein;

(b) the gas is a gas mixture of at least two biocompatible gases A and B;

(c) gas B is present in an amount of between 50%-99% by volume;

(d) gas B has a water solubility of not more than about 0.5 mM at 25°

C. and one atmosphere and an average molecular weight at least about 4 times that of gas A; and

,

(e) the balance of the mixture is gas A.

2. The injectable contrast agent of claim 1 wherein the aqueous carrier is water.

3. The injectable contrast agent of claim 1 wherein gas B is perfluoropropane.

4. The injectable contrast agent of claim 1 wherein gas B is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoro methylcyclobutanes, perfluorohexanes, perfluorocyclohexanes, perfluoro methyl cyclopentanes, perfluoro dimethyl cyclopentanes, perfluoro heptanes, perfluoro cycloheptanes, perfluoro cycloheptanes, perfluoromethyl cyclohexanes, perfluoro dimethyl cyclopentanes, perfluoro trimethyl cyclobutanes perfluoro triethylamines.

5. The injectable contrast agent of claim 1 wherein gas B is selected from group consisting of perfluoropropanes, perfluorobutanes, perfluoropentanes, perfluorohexanes and perfluoro heptanes.

6. The injectable contrast agent of claim 1 wherein gas A is selected from oxygen, nitrogen and carbon dioxide.

7. The injectable contrast agent of claim 1 wherein gas A is air.

8. The injectable contrast agent of claim 1 wherein at least one surfactant is a phospholipid.

9. The injectable contrast agent of claim 1 wherein at least one surfactant comprises a mixture of phospholipids.

19. The injectable contrast agent of claim 1 wherein gas A and gas B are present in a molar ratio of between about 1:

1 to about 1;

50.

10. An injectable ultrasound contrast agent comprising:

(a) a suspension of gas filled microbubbles or microballoons in a physiologically acceptable aqueous carrier comprising a surfactant comprised of at least one phospholipid wherein;

(b) the gas is a gas mixture of at least two biocompatible gases A and B;

(c) gas B is present in an amount of between 0.5-50% by volume;

(d) gas B has a water solubility of not more than about 0.5 mM at 25°

C. and one atmosphere and an average molecular weight at least about 4 times that of gas A; and

,

(e) the balance of the mixture is gas A.

11. The injectable contrast agent of claim 10 wherein the physiological aqueous carrier is water.

12. The injectable contrast agent of claim 10 wherein gas B is perfluoropropane.

13. The injectable contrast agent of claim 10 wherein gas B is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoro methylcyclobutanes, perfluorohexanes, perfluorocyclohexanes, perfluoro methyl cyclopentanes, perfluoro dimethyl cyclopentanes, perfluoro heptanes, perfluoro cycloheptanes, perfluoro perfluoro trimethyl cycloheptanes, perfluoromethyl cyclohexanes, perfluoro dimethyl cyclopentanes, cyclobutanes perfluoro triethylamines.

14. The injectable contrast agent of claim 10 wherein gas B is selected from group consisting of perfluoropropanes, perfluorobutanes, perfluoropentanes, perfluorohexanes and perfluoroheptanes.

15. The injectable contrast agent of claim 10 wherein gas A is selected from oxygen, nitrogen and carbon dioxide.

16. The injectable contrast agent of claim 10 wherein gas A is air.

17. The injectable contrast agent of claim 10 wherein said surfactant comprises a mixture of phospholipids.

18. The injectable contrast agent of claim 10 wherein gas A and gas B are present in a molar ratio of between about 50:

1 to about 1;

1.

20. The injectable contrast agent of claim 10 further comprising additives and stabilizers.